Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
08.10.24 | Neuvivo files NDA seeking FDA approval for ALS treatment | ||
07.10.24 | AstraZeneca to license CSPC Pharmaceutical's lipid-lowering therapy | ||
04.10.24 | FDA grants priority review for AstraZeneca's Calquence sNDA | ||
03.10.24 | FDA grants fast track status for Volastra's VLS-1488 to treat ovarian cancer | ||
01.10.24 | FDA grants approval for Fresenius-Formycon's biosimilar Otulfi | ||
30.09.24 | AbbVie seeks FDA approval for non-small cell lung cancer treatment | ||
27.09.24 | Acumen Pharmaceuticals extends collaboration with Lonza for sabirnetug | ||
26.09.24 | MITEM PHARMA acquires global rights to injectable medicine from Novartis | ||
25.09.24 | Amgen's TEPEZZA gets Japan's MHLW approval for thyroid eye disease treatment | ||
24.09.24 | FDA grants fast track designation for Elevation Oncology's EO-3021 | ||
23.09.24 | EMA CHMP recommends AbbVie's mirvetuximab soravtansine for ovarian cancer | ||
20.09.24 | Hyphens Pharma introduces new eczema hand balm | ||
19.09.24 | Azitra's ATR-04 receives FDA fast track status for treating skin rash | ||
18.09.24 | FDA grants orphan drug status to Papillon Therapeutics' PPL-001 | ||
17.09.24 | MinervaX collaborates with Wacker Biotech for GBS vaccine production | ||
16.09.24 | Novavax announces availability of Covid-19 vaccine in US pharmacies | ||
13.09.24 | China NMPA approves Keymed Biosciences' Stapokibart for atopic dermatitis | ||
12.09.24 | ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy | ||
11.09.24 | Merck KGaA introduces single-use reactor to accelerate ADC manufacturing | ||
10.09.24 | Osivax and KM Biologics sign deal for influenza vaccine in Japan | ||
09.09.24 | Superluminal Medicines secures $120m in Series A funding round | ||
06.09.24 | Moderna's updated Covid-19 vaccine receives positive EMA CHMP opinion | ||
05.09.24 | Novartis begins construction works at two RLT manufacturing facilities in US | ||
04.09.24 | UK MHRA grants authorisation for Moderna's updated Covid-19 vaccine | ||
03.09.24 | Skyline Therapeutics secures FDA orphan drug status for RP therapy |